A comprehensive view of Capsules / Pills / Tablets. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Chemicals Industry Market Intelligence Service.
Cofepris issues favorable opinion for Pfizer's oral COVID-19 treatment, enabling potential nationwide distribution in Mexico; the Commission is expected to make a final ruling in the coming weeks
Published:
April 24, 2024
by CE Noticias Financieras (Latin America)
|
KORSCH America receives an Exhibitor Award at INTERPHEX NYC for their recently launched X 5 Tablet Press; the press is designed for increased single-sided output and flexibility in high-volume environments
Published:
April 24, 2024
by WhatTheyThink
|
The FDA approves ViiV Healthcare’s Dovato (dolutegravir/lamivudine) for adolescents aged 12 and above for the treatment of HIV-1 infection; Dovato offers a single-tablet, two-drug oral regimen for HIV therapy
Published:
April 08, 2024
by GSK Group (GlaxoSmithKline)
|
Evonik highlights its EUDRAGIT brand of polymers as key ingredients in coating systems for pharmaceuticals; company introduces EUDRACAP, an option for enteric capsule production
Published:
April 04, 2024
by Evonik Industries AG
|
Upsher-Smith Laboratories launches Methimazole tablets, USP, 5 mg and 10 mg., in the US with potential market value of US$36.8M; original reference is Pfizer's brand Tapazole
Published:
April 01, 2024
by M2 Pharma
|
Ask us about our Chemicals Industry market view